Profile data is unavailable for this security.
About the company
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
- Revenue in USD (TTM)0.00
- Net income in USD-1.53m
- Incorporated2017
- Employees--
- LocationGelteq LtdLevel 4, 100 Albert RoadMELBOURNE 3205AustraliaAUS
- Phone+61 39087-3990
- Websitehttps://www.gelteq.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Integrated BioPharma, Inc. | 50.32m | 112.00k | 9.63m | 147.00 | 121.21 | 0.5007 | 21.74 | 0.1914 | 0.0026 | 0.0026 | 1.62 | 0.6391 | 1.95 | 4.32 | 10.96 | 342,292.50 | 0.4338 | 13.15 | 0.5505 | 19.97 | 7.72 | 11.22 | 0.2226 | 5.87 | 1.08 | -- | 0.0004 | -- | -0.7006 | 0.1357 | 806.25 | -41.77 | 5.96 | -- |
| Aytu Biopharma Inc | 81.00m | -15.84m | 10.73m | 99.00 | -- | 0.376 | -- | 0.1325 | -2.86 | -2.86 | 14.63 | 4.64 | 0.6364 | 2.15 | 3.08 | 818,202.00 | -12.45 | -27.76 | -25.70 | -46.03 | 67.39 | 58.88 | -19.56 | -56.45 | 0.7916 | -0.0594 | 0.3531 | -- | -24.58 | 61.73 | 7.08 | -- | -- | -- |
| Bio Essence Corp | 593.21k | -1.02m | 12.07m | 12.00 | -- | -- | -- | 20.34 | -0.0278 | -0.0156 | 0.0158 | -0.0458 | 0.3305 | -- | 21.20 | -- | -57.09 | -46.10 | -- | -- | 25.05 | 33.89 | -172.74 | -111.21 | -- | -59.99 | 7.03 | -- | -11.27 | -10.94 | -52.03 | -- | -48.19 | -- |
| NDT Pharmaceuticals Inc | -100.00bn | -100.00bn | 12.59m | 1.00 | -- | 0.0703 | -- | -- | -- | -- | -- | 1.12 | -- | -- | -- | -- | -- | -164.47 | -- | -452.47 | -- | -- | -- | -6,891.36 | -- | -- | 0.00 | -- | -100.00 | -- | 87.56 | -- | -- | -- |
| Bright Green Corp | 0.00 | -9.92m | 13.41m | 5.00 | -- | 1.35 | -- | -- | -0.0538 | -0.0538 | 0.00 | 0.0519 | 0.00 | -- | -- | 0.00 | -47.48 | -- | -72.55 | -- | -- | -- | -- | -- | -- | -- | 0.0494 | -- | -- | -- | 52.54 | -- | -- | -- |
| Immunoprecise Antibodies Ltd | 17.21m | -19.72m | 13.84m | 102.00 | -- | 0.5583 | -- | 0.804 | -0.7454 | -0.7454 | 0.6581 | 0.8598 | 0.3546 | 6.12 | 6.16 | -- | -40.63 | -26.70 | -46.68 | -30.31 | 48.21 | 56.13 | -114.58 | -85.72 | 0.8189 | -134.72 | 0.3289 | -- | 18.65 | 17.54 | -2.32 | -- | 16.71 | -- |
| Onconetix Inc | 1.46m | -53.12m | 14.43m | 12.00 | -- | -- | -- | 9.86 | -104.90 | -104.90 | 2.89 | 50.92 | 0.0328 | 3.45 | 5.30 | 121,979.20 | -119.09 | -- | -215.11 | -- | -57.21 | -- | -3,629.24 | -- | 0.091 | -11.87 | 0.2984 | -- | -- | -- | -176.78 | -- | -- | -- |
| Gelteq Ltd | 0.00 | -1.53m | 15.01m | -- | -- | 1.06 | -- | -- | -0.1605 | -0.1605 | 0.00 | 1.50 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.38 | -32.41 | 0.0605 | -- | -- | -- | -72.77 | -- | -- | -- |
| Talphera Inc | 398.00k | -13.70m | 15.12m | 15.00 | -- | 1.19 | -- | 38.00 | -0.6353 | -0.6323 | 0.0185 | 0.7491 | 0.0187 | -- | -- | 26,533.33 | -64.37 | -22.60 | -78.11 | -28.55 | -- | -- | -3,443.22 | -714.87 | -- | -- | 0.00 | -- | -- | -21.26 | -119.16 | -- | -34.33 | -- |
| Cumberland Pharmaceuticals, Inc. | 37.79m | -10.38m | 16.53m | 91.00 | -- | 0.6307 | -- | 0.4375 | -0.7328 | -0.7328 | 2.67 | 1.87 | 0.4501 | 0.8643 | 3.17 | 415,225.80 | -12.35 | -7.03 | -17.75 | -9.52 | 82.58 | 79.95 | -27.45 | -17.64 | 1.26 | -38.85 | 0.382 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| Marinus Pharmaceuticals Inc | 31.47m | -140.49m | 16.65m | 165.00 | -- | -- | -- | 0.5292 | -2.47 | -2.47 | 0.5524 | -1.21 | 0.238 | 0.6542 | 7.75 | 190,703.00 | -106.26 | -49.64 | -140.93 | -57.76 | 90.17 | -- | -446.49 | -518.96 | 1.47 | -10.06 | -- | -- | 21.63 | -- | -613.59 | -- | 7.47 | -- |
| TherapeuticsMD Inc | 996.00k | -4.83m | 17.27m | 1.00 | -- | 0.6239 | -- | 17.33 | -0.4348 | -0.5538 | 0.0889 | 2.40 | 0.0212 | -- | 0.5048 | 996,000.00 | -10.31 | -53.35 | -13.13 | -111.61 | 45.08 | 86.67 | -485.34 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| Cara Therapeutics Inc | 11.00m | -111.08m | 17.78m | 55.00 | -- | 1.53 | -- | 1.62 | -2.04 | -2.04 | 0.2017 | 0.2115 | 0.1063 | 1.10 | 2.10 | 199,927.30 | -107.38 | -35.76 | -132.61 | -40.82 | 74.66 | -- | -1,010.20 | -162.10 | 4.48 | -- | 0.00 | -- | -49.92 | 9.26 | -38.65 | -- | 100.66 | -- |
| DH Enchantment Inc | 100.00 | -173.19k | 19.54m | 1.00 | -- | -- | -- | 195,396.80 | -0.0002 | -0.0002 | 0.00 | -0.0012 | 0.0438 | 0.1493 | -- | 100.00 | -7,579.43 | -- | -- | -- | 0.00 | -- | -173,190.00 | -- | 0.0029 | -14.85 | -- | -- | -95.43 | -- | 59.53 | -- | -- | -- |
| Cyclo Therapeutics Inc | 1.13m | -20.74m | 20.66m | 8.00 | -- | -- | -- | 18.24 | -0.9104 | -0.9104 | 0.0474 | -0.1785 | 0.242 | 0.4002 | 13.16 | 141,553.80 | -443.08 | -132.22 | -- | -215.17 | 91.56 | 90.37 | -1,831.29 | -1,114.04 | 0.4283 | -- | -- | -- | -21.76 | 1.25 | -29.81 | -- | -3.95 | -- |
Data as of Nov 13 2024. Currency figures normalised to Gelteq Ltd's reporting currency: US Dollar USD
